DRY EYE BREAKTHROUGHS
Dry Eye is the most common anterior segment disease presenting to eyecare providers world-wide and represents the easiest pathway for medical eyecare management. Approximately 40 million Americans have dry eye disease.
Blepharitis and Meibomian Gland Dysfunction are common findings in ocular surface disease in up to 86% of patients. Lemp MA, et al. Distribution of aqueous deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012:31(5):472-478. Blepharitis and MGD result in mechanical blockage of the meibomian gland orifice which can manifest as dry eye disease. Removal of bacterial and Demodex biofilms on the eyelid/meibomian line margin is crucial for restoring normal function to the glands. (See photo below for example of lid margin build up of biofilms and demodex debris blocking meibomian gland function.)
“Blephadex is one of the best Non-RX products I have used with patients.”
The combination of Tea Tree Oil and Coconut Oil found in Blephadex has been an effective, comfortable and easy-to-use treatment for patients with symptoms of blepharitis and Demodex. Patients’ symptoms like watering and itching eyes are remarkably better after 3-4 weeks of use. It’s become our go-to product for blepharitis and is great for ongoing maintenance as a lid hygiene product.
